Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Wall

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Neuron|June 20, 2014
Triad3A regulates synaptic strength by ubiquitination of ArcAngela M Mabb, H Shawn Je, Mark J Wall, et al.
Neuropharmacology|February 13, 2022
The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophreniaJessica Brown, Luisa Iacovelli, Gabriele Di Cicco, et al.
Neuropharmacology|August 10, 2020
Pharmacological activation of mGlu5 receptors with the positive allosteric modulator VU0360172, modulates thalamic GABAergic transmissionRoberta Celli, Mark J Wall, Ines Santolini, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2018
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca<sub>v</sub> 2.2) blockers for the treatment of painMark J Wall, Nalin L Subasinghe, Michael P Winters, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.
Neuron|June 5, 2018
The Temporal Dynamics of Arc Expression Regulate Cognitive FlexibilityMark J Wall, Dawn R Collins, Samantha L Chery, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitorsSanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsCarl R Illig, Jinsheng Chen, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitorsKenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Neuron|June 20, 2014
Triad3A regulates synaptic strength by ubiquitination of ArcAngela M Mabb, H Shawn Je, Mark J Wall, et al.
Neuropharmacology|February 13, 2022
The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophreniaJessica Brown, Luisa Iacovelli, Gabriele Di Cicco, et al.
Neuropharmacology|August 10, 2020
Pharmacological activation of mGlu5 receptors with the positive allosteric modulator VU0360172, modulates thalamic GABAergic transmissionRoberta Celli, Mark J Wall, Ines Santolini, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2018
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca<sub>v</sub> 2.2) blockers for the treatment of painMark J Wall, Nalin L Subasinghe, Michael P Winters, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
A novel series of pyrazolylpiperidine N-type calcium channel blockersNalin L Subasinghe, Mark J Wall, Michael P Winters, et al.
Neuron|June 5, 2018
The Temporal Dynamics of Arc Expression Regulate Cognitive FlexibilityMark J Wall, Dawn R Collins, Samantha L Chery, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitorsSanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsCarl R Illig, Jinsheng Chen, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitorsKenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Pageof 8